Showing results (251-260 of 417) with videos related to
Sort By:
Pageof 42
Hepatology (Baltimore, Md.)|July 22, 2014
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkVictor J Navarro, Huiman Barnhart, Herbert L Bonkovsky, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 19, 2014
Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosisJacqueline G O'Leary, K Rajender Reddy, Florence Wong, et al.Gastroenterology|September 7, 2010
Induction pegylated interferon alfa-2a and high dose ribavirin do not increase SVR in heavy patients with HCV genotype 1 and high viral loadsK Rajender Reddy, Mitchell L Shiffman, Maribel Rodriguez-Torres, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2026
Validation of THCC-RI in the Hepatocellular Carcinoma Early Detection Strategy (HEDS) StudyFasiha Kanwal, Camden Lopez, Jing Ning, et al.Alimentary Pharmacology & Therapeutics|March 2, 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairmentMark Sulkowski, Laura E Telep, Massimo Colombo, et al.Annals of Hepatology|April 7, 2023
Early living donor liver transplantation for alcohol-associated hepatitisAnand V Kulkarni, Raghuram Reddy, Juan Pablo Arab, et al.Journal of Viral Hepatitis|March 5, 2021
Willingness to participate in research among black patients with liver disease: A national cross-sectional studyF Hunter McGuire, Kat André, Minyone L Bradsher, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 30, 2018
Neutrophil-to-Lymphocyte Ratio Associates Independently With Mortality in Hospitalized Patients With CirrhosisJonathan Rice, Jennifer L Dodge, Kiran M Bambha, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 26, 2011
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis CSarah J Schrieber, Roy L Hawke, Zhiming Wen, et al.Vaccine|November 14, 2022
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipientsAnand V Kulkarni, Shashidhar Jaggaiahgari, Sowmya Iyengar, et al.Pageof 42